VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced that an affiliate has acquired Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. Bausch + Lomb indicated that the acquisition will expand its surgical presence in the United States and contribute to its position in the field of dry eye. A U.S.-based privately held ophthalmic medical diagnostic company, Trukera Medical commercializes the ScoutPro Osmolarity System, an automated device intended to quantitatively measure the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in conjunction with other methods of clinical evaluation. Read More